Entarica 1 Tablet
Marketer
Fibrica Healthcare Pvt Ltd
Salt Composition
Entecavir (1mg)
Overview Entarica 1 Tablet
Hepatitis B (HBV) infection is treated with the antiviral entecavir. This medication inhibits viral replication, lowering HBV levels and slowing liver damage. Entarica 1 Tablet, taken on an empty stomach as prescribed, must be administered precisely as directed. Consistent dosing maximizes efficacy, improving liver function and minimizing chronic HBV complications. Whether Entarica 1 Tablet prevents liver cancer or cirrhosis remains undetermined. Continue treatment until your physician advises discontinuation; missed doses should be avoided. Headache, nausea, vomiting, abdominal pain, fatigue, and diarrhea are common, usually mild side effects. Report persistent or troublesome symptoms. Rarely, skin reactions or liver injury may occur, necessitating close initial monitoring. Inform your doctor of any pre-existing skin conditions or kidney disease before starting treatment. Regular blood tests to assess blood counts and liver function are often required. Alcohol consumption should be avoided due to increased liver damage risk. Pregnant or breastfeeding individuals should consult their doctor. If HIV-positive, avoid unprotected sex and sharing personal items; discuss safe sex practices with your doctor to prevent HIV transmission.
Primary Ingredients of Entarica 1 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Entarica 1 Tablet
Persistent infection with the hepatitis B virus (HBV)
Major Benefits of Entarica 1 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Entarica (one tablet) on an empty stomach.
Common Side effects of Entarica 1 Tablet:
- Headache
- Nausea
- Vomiting
- Fatigue
- Stomach pain
- Diarrhea
How to use Entarica 1 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Entarica (one tablet) on an empty stomach.
How Entarica 1 Tablet works:
One Entarica tablet offers antiviral action by inhibiting viral replication within human cells. This halts further viral production, thereby resolving the infection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Entarica 1 Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Entarica 1 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Entarica 1 Tablet is likely inadvisable. Scant available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking one Entarica tablet can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is strongly discouraged if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Entarica 1 Tablet cautiously. Dosage modification for Entarica 1 Tablet may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Entarica 1 Tablet poses no safety concerns for patients with hepatic impairment; dose modification is unnecessary.
What if you forget to take Entarica 1 Tablet :
Should you forget a dose of Entarica 1 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Entarica 1 Tablet
| Label | Value |
|---|---|
| Chemical Type | Base analog nucleotide |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Action Class | Reverse transcriptase inhibitors (RTIs) targeting nucleosides/nucleotides |






